Personal genetics startup 23andMe is back — and it wants to tell you what your genes have to do with how much coffee you drink

It's been two years since genetic testing startup 23andMe was
allowed to provide health reports for their signature test,
after the FDA made them stop.

But as of today, the
$1.1-billion company is ready to relaunch that health
component — this time with the FDA's support — with
its Personal Genome Service (PGS).

The tests will cost $199, double the current price of the
ancestry component of the test alone.

In total, 23andMe will provide more than 60 reports based on the
samples of spit you submit, which are then
sifted and scanned it for
single genetic variationsthat are linked to
specific traits, like hair and eye color and propensity for
certain diseases.

Shows you genes you can pass on to your
children

One of the additional tests included in the
relaunch is a "carrier status" test, which can be used to
tell users if they have a genetic mutation or if they
carry a copy of a recessive (non-expressed) gene that
could still be passed down to their children.

But the new reports come with a big disclaimer:

The test collection will have to be done in FDA-approved
containers, and it won't be able to be used as a "diagnostic
tool." This means the tests won't give you an estimate
of your risk of developing certain diseases (which the old
test did) or tell you your likelihood
of passing along a specific genetic disease to
your children.

Fills you in on how your DNA relates to everything from alcohol
consumption to muscle composition

The new test's wellness component is also supposed to fill you in
on how your DNA relates to your alcohol, caffeine, and milk
consumption, as well as your muscle composition by showing
you how your habits relate to other 23andMe customers with a
similar genetic makeup.

Here's what the caffeine results page looks like:

23andMe

This makes 23andMe the first direct-to-consumer genetic test that
meets the FDA's standards. Other tests have to have a
doctor involved.

And, the company says, the reports will be updated as more
genetic information comes in.